09.12.2009 • Topics

Lonza to Build Cell Therapy Facility in Singapor

Swiss drugs industry supplier Lonza Group said it was building a new facility in Singapore to expand its cell therapy business. Lonza said that the total investment for the first phase would be approximately 30 million Swiss francs ($27.03 million). Construction is due to begin in early 2010 and the facility is expected to be operational by mid-2011, it added. "The facility will operate with cutting-edge technologies and a skilled labor force, allowing it to readily meet the needs of a broad range of customers and address the growing global demand for Cell Therapies," said Lonza CEO Stefan Borgas in a statement.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.